Gene dosage determines the behavioural phenotype in the 5xFAD mouse model of Alzheimer's disease: analysis of the contribution of brain insulin signalling and gut …

D Medina-Vera, EN Zambrana-Infantes… - 2022 - researchsquare.com
… HTZ and HZ mice exhibited hippocampal impairment caused … that amyloid plaques are
deposited in the hippocampalmouse models, such as 3xTg-AD, which exhibited changes

[HTML][HTML] Rodent models of amyloid-beta feature of Alzheimer's disease: development and potential treatment implications

CH Poon, Y Wang, ML Fung, C Zhang… - Aging and disease, 2020 - ncbi.nlm.nih.gov
… : APP and PS1 genes, a 3xTg-AD mouse model was generated to … ) failed to alter hippocampal
BDNF levels in mice, but this … Drugs, such as Latrepirdine (Dimebon), which was shown to …

[HTML][HTML] Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research

M Yuan, Y Wang, Z Huang, F Jing, P Qiao… - Journal of Biomedical …, 2023 - ncbi.nlm.nih.gov
… The major pathological changes in AD progression are the … before extracellular amyloid
deposition in five AD mice models [77… , but is activated in the hippocampus in AD patients. ErbB2 …

[PDF][PDF] Characterization of the new htau-KI mouse model for Alzheimer's disease with a focus on the role of immune cells during progressing cerebral amyloidosis

S Barendrecht - 2021 - opendata.uni-halle.de
… LTP in the CA1 region of the hippocampus at 8 months of age. ...… to pathological changes in
the central nervous system (CNS) … pathology under progressing amyloid pathology in htau-KI …

[HTML][HTML] Indolylazine derivative induces chaperone expression in aged neural cells and prevents the progression of Alzheimer's disease

VF Lazarev, EA Dutysheva, ER Mikhaylova… - Molecules, 2022 - mdpi.com
… ageing due to the significant changes in the glutathione redox … to reveal that 3xTg-AD and
Tg-APP/PS1 mice were much less … containing Aβ42 in the mouse hippocampus, we used the …

Drug Discovery from Medicinal Plants against Alzheimer's Disease

MM Marzouk, MM Farid, NM Hegazi… - … Drug Discovery for …, 2023 - Wiley Online Library
… , RVT- 101), and latrepirdine (Dimebon) were evaluated as novel … eliminate amyloid plaques
in mice cortex and hippocampus … Berberine ameliorates β- amyloid pathology, gliosis, and …

[HTML][HTML] Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease

M Svensson, E Andersson, O Manouchehrian… - Scientific Reports, 2020 - nature.com
… not detect any statistically significant changes on the levels of … plaques in the hippocampus
(p = 0.08) of running mice, in line … of Dimebon does not ameliorate amyloid-beta pathology in …

[HTML][HTML] Role of receptors in relation to plaques and tangles in Alzheimer's disease pathology

K Sharma, S Pradhan, LK Duffy, S Yeasmin… - International Journal of …, 2021 - mdpi.com
3xTg-AD model mice experienced a reduction in both Aβ and tangles in the hippocampus
and cortex… M1 mAChR’s significance to APP processing and amyloid pathology has also been …

Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer's disease

R Dhapola, P Sarma, B Medhi, A Prakash… - Molecular …, 2022 - Springer
… Similarly study on APP mice models of Alzheimer’s disease … of neurogenesis activity of
hippocampus, changes in insulin … the safety and effectiveness of Dimebon in mild to moderate …

Calcium Channels as a Potential Therapeutic Target for Alzheimer's Disease

P Sharma, P Thapak, B Chandwani, H Kharkwal… - … Drug Targets for …, 2023 - Springer
… and amyloid-β accumulation. The disruption in calcium homeostasis accompanies changes
as observed in the whole brain pathology of … in hippocampal neurons of 3XTg-AD mice. The …